Your browser doesn't support javascript.
loading
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones.
Chaves, Otávio Augusto; Fintelman-Rodrigues, Natalia; Wang, Xuanting; Sacramento, Carolina Q; Temerozo, Jairo R; Ferreira, André C; Mattos, Mayara; Pereira-Dutra, Filipe; Bozza, Patrícia T; Castro-Faria-Neto, Hugo Caire; Russo, James J; Ju, Jingyue; Souza, Thiago Moreno L.
Afiliação
  • Chaves OA; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro 21040-900, Brazil.
  • Fintelman-Rodrigues N; National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro 21040-900, Brazil.
  • Wang X; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro 21040-900, Brazil.
  • Sacramento CQ; National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro 21040-900, Brazil.
  • Temerozo JR; Center for Genome Technology and Biomolecular Engineering, Columbia University, New York, NY 10027, USA.
  • Ferreira AC; Department of Chemical Engineering, Columbia University, New York, NY 10027, USA.
  • Mattos M; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro 21040-900, Brazil.
  • Pereira-Dutra F; National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro 21040-900, Brazil.
  • Bozza PT; Laboratory on Thymus Research, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro 21040-900, Brazil.
  • Castro-Faria-Neto HC; National Institute for Science and Technology on Neuroimmunomodulation (INCT/NIM), Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro 21040-900, Brazil.
  • Russo JJ; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro 21040-900, Brazil.
  • Ju J; National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro 21040-900, Brazil.
  • Souza TML; Preclinical Research Laboratory, Universidade Iguaçu-UNIG, Nova Iguaçu 26260-045, Brazil.
Viruses ; 14(7)2022 06 30.
Article em En | MEDLINE | ID: mdl-35891437
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Flavonas / Tratamento Farmacológico da COVID-19 / Isoflavonas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Flavonas / Tratamento Farmacológico da COVID-19 / Isoflavonas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article